Jinteli Tablet
Product Images NDC 0093-3122

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Jinteli (NDC 0093-3122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram showing two steroid molecules. The left structure is norethindrone acetate, and the right one is ethinyl estradiol, the active ingredients in Jinteli tablets.*

FDA Label Image

Image 2

Two line graphs depicting mean plasma concentrations over 24 hours. The top graph shows mean plasma norethindrone concentration (ng/mL) over time (hours), with a peak around 2 hours and gradual decline thereafter. The bottom graph shows mean plasma ethinyl estradiol concentration (pg/mL) over time (hours), peaking near 2 hours and slowly decreasing through 24 hours.*

FDA Label Image

Image 3

Line graph showing the percentage of patients over 12 months of treatment comparing placebo with Jinteli doses 0.5/2.5 and 1/5. The x-axis represents months of treatment from 1 to 12, and the y-axis shows percentage of patients from 0 to 100. Patient group sizes are noted for placebo (137), Jinteli 0.5/2.5 (136), and Jinteli 1/5 (146).*

FDA Label Image

Image 4

A bar chart depicting mean percent change over 12 and 24 months for three groups: Placebo (white bars), Jinteli 0.5 mg/2.5 ug (black bars), and Jinteli 1 mg/5 ug (gray bars). The chart shows percent increases for Jinteli groups and decreases for Placebo, with statistically significant changes marked by asterisks (p-value <0.001 vs. placebo).*

FDA Label Image

Image 5

Jinteli tablets packaging label showing 1 mg/5 mcg strength of norethindrone acetate and ethinyl estradiol oral tablets. The label indicates 5 blister cards with 28 tablets each and includes storage instructions and manufacturer information for Teva Pharmaceuticals USA, Inc. The label features the proprietary name, generic names, dosage strength, and directions that the product is prescription only.*

FDA Label Image

Image 6

Packaging label for Jinteli tablets, containing norethindrone acetate and ethinyl estradiol. Each tablet has a strength of 1 mg norethindrone acetate and 5 mcg ethinyl estradiol. The label shows the product is supplied in 5 blister cards with 28 tablets each. It is manufactured by Teva Pharmaceuticals USA, Inc. and includes barcode and prescription only information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.